(Reuters) -Swiss generic drug manufacturer Sandoz (SIX:SDZ) said on Monday it had filed an antitrust lawsuit in the United States against Amgen (NASDAQ:AMGN) over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).Sandoz alleges Amgen blocked competition from more cost-effective biosimilar competitors, including Sandoz etanercept biosimilar, Erelzi, ...
Investing.com -- Poland’s central bank is considering interest rate cuts of between 50 and 100 basis points by the end of 2025, according to central banker Wieslaw Janczyk. His comments were made public on Monday through the state news agency PAP.The country’s main interest rate has been steady at 5.75% since October 2023. However, this month, central bank governor Adam Glapinski indicated tha ...
Investing.com -- Greece has inked a deal to purchase anti-ship missiles from France, as announced on Monday. The agreement was officially signed by Nikos Dendias, the Greek Defense Minister, and Sebastien Lecornu, the Armed Forces Minister of France. Lecornu was in Athens for a visit at the time of the signing.This article was generated with the support of AI and reviewed by an editor. For more in ...
By Maggie Fick and Bhanvi SatijaLONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing concerns they will have a harder time getting products approved, investors, company executives and analysts said. Mass firings at the U.S. Food and Drug Administration are particularly ris ...